Early research (Phase 1)Study completedNCT03324373What this trial is testingLenvatinib and Everolimus in Renal Cell Carcinoma (RCC)Who this might be right forRenal Cell Carcinoma Yousef Zakharia 11
Testing effectiveness (Phase 2)Ended earlyNCT02853162What this trial is testingAblative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)Who this might be right forRenal Cell Carcinoma UMC Utrecht 30
Not applicableLooking for participantsNCT07704970What this trial is testingQLESP Block for Pain Control in Robotic Partial NephrectomyWho this might be right forRenal Cell Carcinoma (Kidney Cancer)Postoperative PainNerve Block Huazhong University of Science and Technology 120
Testing effectiveness (Phase 2)UnknownNCT05024318What this trial is testingNeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma, Clear Cell, Somatic Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)Study completedNCT00356460What this trial is testingSafety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaWho this might be right forCarcinoma, Renal CellMelanoma Genzyme, a Sanofi Company 29
Early research (Phase 1)Active Not RecruitingNCT03478462What this trial is testingDose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasWho this might be right forPediatric Solid TumorPediatric LymphomaPediatric Brain Tumor+5 more Cellectar Biosciences, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00459979What this trial is testingSunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by SurgeryWho this might be right forKidney Cancer Case Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05931393What this trial is testingSequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)Who this might be right forRCCRenal Cell Carcinoma University of Texas Southwestern Medical Center 18
Early research (Phase 1)Study completedNCT02762006What this trial is testingNeoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaKidney Cancer Moshe Ornstein 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06127238What this trial is testingStudy of ST-1898 in Advanced Renal Cell CarcinomaWho this might be right forAdvanced Renal Cell Carcinoma Beijing Scitech-Mq Pharmaceuticals Limited 90
Testing effectiveness (Phase 2)WithdrawnNCT03226236What this trial is testingVaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCCWho this might be right forCarcinoma, Renal CellVaccinationSecondary Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Testing effectiveness (Phase 2)Ended earlyNCT00022633What this trial is testingS0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 65
Testing effectiveness (Phase 2)UnknownNCT00005958What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Amgen
Testing effectiveness (Phase 2)Study completedNCT03463681What this trial is testingCaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinomaWho this might be right forMetastatic Renal Cell Carcinoma Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 49
Very early researchLooking for participantsNCT07067905What this trial is testingClinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma and Glioblastoma Chinese PLA General Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04074967What this trial is testingStudy of ARRY-614 Plus Either Nivolumab or Nivolumab+IpilimumabWho this might be right forRenal Cell CarcinomaMelanomaSolid Tumor+2 more Dan Zandberg 70
Early research (Phase 1)Study completedNCT02387307What this trial is testingRSIFN-co in Subjects With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more Sichuan Huiyang Life Science and Technology Corporation 42
Testing effectiveness (Phase 2)Study completedNCT03890731What this trial is testingA Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been CompletedWho this might be right forSolid Cancer Bayer 6
Testing effectiveness (Phase 2)Study completedNCT00918281What this trial is testingReproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) InjectionWho this might be right forSolid TumorsHigh Grade GliomasLung Cancer+4 more GE Healthcare 70
Early research (Phase 1)Looking for participantsNCT05518253What this trial is testingA Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsWho this might be right forMetastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more Weijia Fang, MD 30